737 Inhibition of P21-activated kinase 4 (PAK4) reverts immune exclusion and restores anti-tumor immunity in the tumor microenvironment

737 Inhibition of P21-activated kinase 4 (PAK4) reverts immune exclusion and restores anti-tumor immunity in the tumor microenvironment

Bibliographic Details
Main Authors:	Rajarshi Bhadra, Keith Ching, Johnni Gullo-Brown, Jonathan Heyen, Yu 'Jerry' Zhou, Gina Chu, Eleanore Hendrickson, Brandy Chavez, Indrawan McAlpine, Eugene Rui, Shawn Doran, Sergei Timofeevski, Jennifer Kinong, Szu-Yu Tang, Jon Oyer, Vinayak Rayannavar, Andrew Nager, Stephanie Shi, Christopher Dillon, Murali Gururajan
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2021-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

Editorial: The immunosuppressive tumor microenvironment and strategies to revert its immune regulatory milieu for cancer immunotherapy
by: Mazdak Ganjalikhani Hakemi, et al.
Published: (2023-06-01)

Reverting Immune Suppression to Enhance Cancer Immunotherapy
by: Bella S. Guerrouahen, et al.
Published: (2020-01-01)

Immune checkpoint inhibitors as potential therapy for reverting T-cell exhaustion and reverting HIV latency in people living with HIV
by: José M. Benito, et al.
Published: (2023-12-01)

2.737 Mechatronics, Spring 1999
by: Trumper, David
Published: (1999)

Fayzas revertering
by: Pia Karlsson
Published: (1999-09-01)

Hemostasis and tumor immunity
by: Rachel Cantrell, et al.
Published: (2022-05-01)

Cryoablation reshapes the immune microenvironment in the distal tumor and enhances the anti-tumor immunity
by: Ying Wu, et al.
Published: (2022-08-01)

Tumor-promoting effect and tumor immunity of SRSFs
by: Shuai Zhang, et al.
Published: (2025-03-01)

PRMT1 reverts the immune escape of necroptotic colon cancer through RIP3 methylation
by: Lian Zhang, et al.
Published: (2023-04-01)

An immune suppressive tumor microenvironment in primary prostate cancer promotes tumor immune escape.
by: Angelyn Anton, et al.
Published: (2024-01-01)

Tumor-immune partitioning and clustering algorithm for identifying tumor-immune cell spatial interaction signatures within the tumor microenvironment.
by: Mai Chan Lau, et al.
Published: (2025-02-01)

Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors
by: Liangliang Xu, et al.
Published: (2022-07-01)

Regulation of Tumor Immunity by Tumor/Dendritic Cell Fusions
by: Shigeo Koido, et al.
Published: (2010-01-01)

Influenced tumor microenvironment and tumor immunity by amino acids
by: Min Yu, et al.
Published: (2023-01-01)

Tumor immune microenvironment (TIME) to enhance antitumor immunity
by: Sajin Rajbhandary, et al.
Published: (2023-05-01)

The case for reverting to GST
by: Xavier, John Antony
Published: (2019)

Control revert system.
by: Zaludin, Zairil Azhar
Published: (2007)

Cancer vaccines and tumor immunity /
by: Orentas, Rimas, et al.
Published: (2008)

Editorial: Tumor ablation and immunity
by: Ming Kuang
Published: (2024-02-01)

Ferroptosis, autophagy, tumor and immunity
by: Yuyan Xie, et al.
Published: (2023-09-01)

Tumor Immune Escape and Treatment
by: Wang Yuncong
Published: (2022-01-01)

The ART of tumor immune escape
by: Erik Wennerberg, et al.
Published: (2022-12-01)

1178 Tumor-immune cell targeting chimeras (TICTACs): targeted immune reprogramming of the tumor microenvironment
by: Carolyn R Bertozzi, et al.
Published: (2023-11-01)

Unveiling tumor immune evasion mechanisms: abnormal expression of transporters on immune cells in the tumor microenvironment
by: Lu Chen, et al.
Published: (2023-07-01)

Novel insight into RNA modifications in tumor immunity: Promising targets to prevent tumor immune escape
by: Yuxin Kong, et al.
Published: (2023-07-01)

Exosomes Derived from Immune Cells: The New Role of Tumor Immune Microenvironment and Tumor Therapy
by: Wang S, et al.
Published: (2022-12-01)

The Yin and Yang of Invariant Natural Killer T Cells in Tumor Immunity—Suppression of Tumor Immunity in the Intestine
by: Ying Wang, et al.
Published: (2018-01-01)

CD8+ TIL Recruitment May Revert the Association of MAGE A3 with Aggressive Features in Thyroid Tumors
by: Mariana Bonjiorno Martins, et al.
Published: (2014-01-01)

Stromal and Immune Cell Dynamics in Tumor Associated Tertiary Lymphoid Structures and Anti-Tumor Immune Responses
by: Alessandra Rossi, et al.
Published: (2022-07-01)

Tumor cells utilize acetate for tumor growth and immune evasion
by: Peng Sun, et al.
Published: (2024-09-01)

Regulation of anti-tumor immunity by metal ion in the tumor microenvironment
by: Yaoxin Gao, et al.
Published: (2024-06-01)

Protein S-palmitoylation modification: implications in tumor and tumor immune microenvironment
by: Yijiao Chen, et al.
Published: (2024-02-01)

Exercise-Induced Changes in Tumor Growth via Tumor Immunity
by: Polyxeni Spiliopoulou, et al.
Published: (2021-03-01)

Targeting immune checkpoints on tumor-associated macrophages in tumor immunotherapy
by: Shumin Xu, et al.
Published: (2023-05-01)

The effect of neoadjuvant chemotherapy on the tumor immune microenvironment in gastrointestinal tumors
by: Yujie Wang, et al.
Published: (2022-11-01)

Regulation of tumor immunity and immunotherapy by the tumor collagen extracellular matrix
by: Dallas B. Flies, et al.
Published: (2023-08-01)

Tumor-Derived Exosomes and Their Role in Tumor-Induced Immune Suppression
by: Theresa L. Whiteside
Published: (2016-10-01)

Therapeutic Targeting of Tumor Cells and Tumor Immune Microenvironment Vulnerabilities
by: Balaraman Kalyanaraman, et al.
Published: (2022-06-01)

Identification of immune-related tumor antigens and immune subtypes in osteosarcoma
by: Mingshu Zhang, et al.
Published: (2024-06-01)

Innate immune response restarts adaptive immune response in tumors
by: Wen-shan Li, et al.
Published: (2023-09-01)